Heated chemo bath during stomach cancer surgery shows promise
NCT ID NCT07313579
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at whether giving heated chemotherapy directly into the abdomen during surgery can help prevent stomach cancer from coming back. About 200 adults with advanced stomach cancer that has spread to the lining of the abdomen will receive the treatment. The goal is to see if this approach lowers the chance of cancer returning in the abdomen.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- mitomycin C and cisplatin (heated chemotherapy)
- What this could lead to
- If successful, this approach could reduce the chance of cancer returning in the abdomen for people with advanced gastric cancer.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be less definitive. Heated chemotherapy carries risks like infection, kidney damage, and low blood cell counts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Institute (NCI)
RECRUITINGKyiv, Ukraine
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can immunotherapy outperform chemo after stomach cancer surgery?
- Could a smartphone program supervised by AI boost recovery after stomach cancer surgery?
- Can stomach cancer surgery also tame diabetes?
- Can a modified stomach bypass speed up recovery in advanced gastric cancer?